Eli Casdin
Casdin Capital
Value
1.6B
Stocks
38 Stocks (7 new)
Turnover
6.76%
CIK
1534261
Top Holdings
WGS(24.29%) RVMD(12.75%) BLFS(8.95%) LAB(7.06%) RLAY(6.83%)
About Investor
Established investor leading Casdin Capital, with expertise in fundamental analysis and long-term value creation. Has built a strong track record by focusing on fundamental research and maintaining a consistent investment approach through various market environments.
Investor Philosophy
Specializes in fundamental analysis and long-term value creation through a disciplined investment approach. Emphasizes thorough research, risk management, and identifying opportunities across market cycles. Known for maintaining a consistent strategy while adapting to changing market conditions.
Eli Casdin Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| LABP | Standard BioTools Inc. | Casdin Capital | Nov 28, 2025 | SC 13D/A |
| CDXS | Codexis, Inc. | Casdin Capital | Nov 14, 2025 | SC 13G/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Oct 18, 2025 | SC 13D/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Aug 22, 2025 | SC 13D/A |
| CDXS | Codexis, Inc. | Casdin Capital | Aug 14, 2025 | SC 13G/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Aug 13, 2025 | SC 13D/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Jun 13, 2025 | SC 13D/A |
| CNTY | Century Therapeutics, Inc. | Casdin Capital | May 15, 2025 | SC 13G/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Apr 09, 2025 | SC 13D/A |
| TNYA | Tenaya Therapeutics, Inc. | Casdin Capital | Mar 08, 2025 | SC 13D/A |
| LABP | STANDARD BIOTOOLS INC. | Casdin Capital | Mar 05, 2025 | SC 13D/A |
| NGNM | Neurogene Inc. | Casdin Capital | Feb 14, 2025 | SC 13G/A |
| CNTY | Century Therapeutics, Inc. | Casdin Capital | Nov 27, 2024 | SC 13G |
| CNTY | Century Therapeutics, Inc. | Casdin Capital | Nov 14, 2024 | SC 13G/A |
| NGNM | Neurogene Inc. | Casdin Capital | Nov 08, 2024 | SC 13G |
| CDXS | Codexis, Inc. | Casdin Capital | Sep 26, 2024 | SC 13G |
| LABP | Standard BioTools Inc. | Casdin Capital | Aug 15, 2024 | SC 13D/A |
| LABP | Standard BioTools Inc. | Casdin Capital | Jun 03, 2024 | SC 13D/A |
| LABP | Standard BioTools Inc. | Casdin Capital | May 22, 2024 | SC 13D/A |
| CNTY | Century Therapeutics, Inc. | Casdin Capital | Apr 18, 2024 | SC 13G |
| CNTY | Century Therapeutics, Inc. | Casdin Capital | Apr 09, 2024 | SC 13D/A |
| LABP | Standard BioTools Inc. | Casdin Capital | Mar 20, 2024 | SC 13D/A |
| MXCR | MaxCyte, Inc. | Casdin Capital | Feb 14, 2024 | SC 13G/A |
| RLAY | Relay Therapeutics, Inc. | Casdin Capital | Feb 14, 2024 | SC 13G/A |
| LABP | Standard BioTools Inc. | Casdin Capital | Jan 09, 2024 | SC 13D/A |
| EQRX | EQRx, Inc. | Casdin Capital | Nov 14, 2023 | SC 13D/A |
| BLFS | BioLife Solutions, Inc. | Casdin Capital | Oct 24, 2023 | SC 13D/A |
| RLAY | Relay Therapeutics, Inc. | Casdin Capital | Oct 02, 2023 | SC 13G |
| ABSI | Absci Corporation | Casdin Capital | May 08, 2023 | SC 13D/A |
| ABSI | Absci Corporation | Casdin Capital | Mar 20, 2023 | SC 13D/A |
| DMTK | Dermtech, Inc. | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| TNGX | Tango Therapeutics, Inc. | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| NVTA | Invitae Corporation | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| MGTA | Magenta Therapeutics, Inc. | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| CDXS | Codexis, Inc. | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| VERV | Verve Therapeutics, Inc. | Casdin Capital | Feb 14, 2023 | SC 13G/A |
| ABSI | Absci Corporation | Casdin Capital | Feb 13, 2023 | SC 13D/A |
| MXCR | MaxCyte, Inc. | Casdin Capital | Jan 10, 2023 | SC 13G/A |
